Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 12:44 AM
NCT ID:
NCT03469167
Eligibility Criteria:
Inclusion Criteria:
* Peptic ulcer with high-risk stigmata of recent hemorrhage (Forrest class IA, IB, IIA and IIB)
Exclusion Criteria:
* Subjects who have a history of malignant tumor in upper gastro-intestinal site
* Subjects with platelet and coagulation dysfunction (PLT \< 50E9/L, INR \> 2)
* Subjects that have taken anticoagulant drugs or non-steroidal anti-inflammatory drugs within 72 hours after the treatment
* Subjects with one or more bleeding sources
* Subjects who are pregnant or breast-feeding
* Subject who are allergic or have a hypersensitive reaction to Hydroxyethyl-cellulose or EGF
* Subjects who have undergone endoscopically therapies within the last 7 days
* Subjects who are considered not suitable for the study by significant disease
* Subjects who are not able to comply with the study requirements
* Subjects who are currently enrolled in another clinical study which can impact the study within 30 days of screening
* Subjects who are considered not suitable for the study by the investigator
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT03469167
Study Brief:
Protocol Section:
NCT03469167